SPARQL | HTML5 RDFa and Microdata document
https://identifiers.org/chebi/CHEBI:132933
https://identifiers.org/chebi/CHEBI:16113
https://identifiers.org/chebi/CHEBI:16247
https://identifiers.org/chebi/CHEBI:17855
https://identifiers.org/chebi/CHEBI:39027
https://identifiers.org/chebi/CHEBI:47774
https://identifiers.org/chebi/CHEBI:47775
https://identifiers.org/chebi/CHEBI:64005
https://identifiers.org/chebi/CHEBI:64007
https://identifiers.org/chebi/CHEBI:6495
https://identifiers.org/ensembl/ENSG00000084674
https://identifiers.org/ensembl/ENSG00000087237
https://identifiers.org/ensembl/ENSG00000100979
https://identifiers.org/ensembl/ENSG00000110244
https://identifiers.org/ensembl/ENSG00000112964
https://identifiers.org/ensembl/ENSG00000118137
https://identifiers.org/ensembl/ENSG00000120915
https://identifiers.org/ensembl/ENSG00000130164
https://identifiers.org/ensembl/ENSG00000157978
https://identifiers.org/ensembl/ENSG00000158773
https://identifiers.org/ensembl/ENSG00000158874
https://identifiers.org/ensembl/ENSG00000166035
https://identifiers.org/ensembl/ENSG00000169174
https://identifiers.org/ensembl/ENSG00000175445
https://identifiers.org/ensembl/ENSG00000213398
https://identifiers.org/ensembl/ENSG00000277494
https://identifiers.org/wikipathways/WP5109
http://rdf.wikipathways.org/Pathway/WP5109_r136557/Complex/b3fe7
http://rdf.wikipathways.org/Pathway/WP5109_r136557/Complex/f4615
http://rdf.wikipathways.org/Pathway/WP5109_r136557/ComplexBinding/b3fe7
http://rdf.wikipathways.org/Pathway/WP5109_r136557/ComplexBinding/f4615
http://rdf.wikipathways.org/Pathway/WP5109_r136557/WP/Interaction/a2c6e
http://rdf.wikipathways.org/Pathway/WP5109_r136557/WP/Interaction/aa831
http://rdf.wikipathways.org/Pathway/WP5109_r136557/WP/Interaction/aa9e3
http://rdf.wikipathways.org/Pathway/WP5109_r136557/WP/Interaction/b975d
http://rdf.wikipathways.org/Pathway/WP5109_r136557/WP/Interaction/c62a3
http://rdf.wikipathways.org/Pathway/WP5109_r136557/WP/Interaction/d1300
http://rdf.wikipathways.org/Pathway/WP5109_r136557/WP/Interaction/d7b61
http://rdf.wikipathways.org/Pathway/WP5109_r136557/WP/Interaction/d9fea
http://rdf.wikipathways.org/Pathway/WP5109_r136557/WP/Interaction/dfa30
http://rdf.wikipathways.org/Pathway/WP5109_r136557/WP/Interaction/e5190
http://rdf.wikipathways.org/Pathway/WP5109_r136557/WP/Interaction/e7133
http://rdf.wikipathways.org/Pathway/WP5109_r136557/WP/Interaction/e9e9b
http://rdf.wikipathways.org/Pathway/WP5109_r136557/WP/Interaction/f3899
http://rdf.wikipathways.org/Pathway/WP5109_r136557/WP/Interaction/f3f7e
http://rdf.wikipathways.org/Pathway/WP5109_r136557/WP/Interaction/fb880
http://rdf.wikipathways.org/Pathway/WP5109_r136557/WP/Interaction/fc82e
http://rdf.wikipathways.org/Pathway/WP5109_r136557/WP/Interaction/fd1b3
http://rdf.wikipathways.org/Pathway/WP5109_r136557/WP/Interaction/fd4c2
http://rdf.wikipathways.org/Pathway/WP5109_r136557/WP/Interaction/fe7b9
http://rdf.wikipathways.org/Pathway/WP5109_r136557/WP/Interaction/id7d752779
http://rdf.wikipathways.org/Pathway/WP5109_r136557/WP/Interaction/idddfd35b4
http://rdf.wikipathways.org/Pathway/WP5109_r136557/WP/Interaction/idf9de3300
https://identifiers.org/wikipathways/WP5109_r136557
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://vocabularies.wikipathways.org/wp#Pathway
http://www.w3.org/2004/02/skos/core#Collection
http://vocabularies.wikipathways.org/wp#cellTypeOntologyTag
http://purl.obolibrary.org/obo/CL_0000182
http://vocabularies.wikipathways.org/wp#diseaseOntologyTag
http://purl.obolibrary.org/obo/DOID_1168
http://purl.obolibrary.org/obo/DOID_13809
http://purl.obolibrary.org/obo/DOID_13810
http://vocabularies.wikipathways.org/wp#isAbout
http://rdf.wikipathways.org/Pathway/WP5109_r136557
http://vocabularies.wikipathways.org/wp#ontologyTag
http://vocabularies.wikipathways.org/wp#Curation:AnalysisCollection
http://purl.obolibrary.org/obo/PW_0000013
http://vocabularies.wikipathways.org/wp#Curation:RareDiseases
http://purl.obolibrary.org/obo/CL_0000182
http://purl.obolibrary.org/obo/DOID_1168
http://purl.obolibrary.org/obo/DOID_13809
http://purl.obolibrary.org/obo/DOID_13810
http://vocabularies.wikipathways.org/wp#organism
http://purl.obolibrary.org/obo/NCBITaxon_9606
http://vocabularies.wikipathways.org/wp#organismName
http://vocabularies.wikipathways.org/wp#pathwayOntologyTag
http://purl.obolibrary.org/obo/PW_0000013
http://xmlns.com/foaf/0.1/img
https://www.wikipathways.org//wpi/wpi.php?action=downloadFile&type=png&pwTitle=Pathway:WP5109&oldid=136557
https://www.wikipathways.org//wpi/wpi.php?action=downloadFile&type=svg&pwTitle=Pathway:WP5109&oldid=136557
http://xmlns.com/foaf/0.1/page
http://www.wikipathways.org/instance/WP5109_r136557
http://purl.org/dc/elements/1.1/identifier
https://identifiers.org/wikipathways/WP5109
http://purl.org/dc/elements/1.1/source
http://purl.org/dc/elements/1.1/title
Familial hyperlipidemia type 2
http://purl.org/dc/terms/description
Familial hyperlipidemias are classified according to the Fredrickson classification. Type II familial hyperlipidemia is divided into 2 subtypes, IIa and IIb.
IIa is linked with mutations in the LDL receptor (LDLR) or genes that regulate the LDL uptake. Therefore, we see an increase of LDL with type IIa familial hyperlipidemia. IIa can be subdived into 4 different types. FHCL1 is caused by direct mutations of the LDLR. This FCHL1 has different phenotypes linked to it which are cause by mutations in APOA2, EPHX2 and GHR. FCHL2 is caused by mutations in APOB, which acts as a ligand for the LDLR. FHCL3 is caused by mutations in PCSK9 which binds to LDLR to inhibit LDL uptake. Lastly, FHCL4 is linked with mutations in LDLRAP1, which stimulates receptor binding.
Typ IIB familial hyperlipidemia is known as familial combined hyperlipidemia. This type has shown an increase of both LDL and VLDL. Type IIB can be divided into 3 subtypes. FCHL1 is caused by mutations in USF1 which plays a role in cellular transcription. However, it is unclear how exactly this is linked to the lipid metabolism. HYPLIP2 is caused by mutations in APOB, which is linked to the reduced LDL. APOB is also a primmary apolipoprotein for VLDL. Lastly, FCHL3 is linked to LPL mutations, which is mostly linnked to hydrolizing the VLDL into IDL.
http://purl.org/dc/terms/identifier
http://purl.org/spar/cito/cites
https://identifiers.org/pubmed/29100061
https://identifiers.org/pubmed/29298899
https://identifiers.org/pubmed/28766509
https://identifiers.org/pubmed/23055695
https://identifiers.org/pubmed/24426196
https://identifiers.org/pubmed/25110901
https://identifiers.org/pubmed/22461740
https://identifiers.org/pubmed/30249788
https://identifiers.org/pubmed/30333156
https://identifiers.org/pubmed/30420806
https://identifiers.org/pubmed/31676439
https://identifiers.org/pubmed/31462513
https://identifiers.org/pubmed/32120838
https://identifiers.org/pubmed/26725424
https://identifiers.org/pubmed/26247089
https://identifiers.org/pubmed/12910492
https://identifiers.org/pubmed/27809445